VINCRISTINE Pfizer 2 mg/2ml 5 flac 2 ml
7680536400609
CH-53640
L01CA02
07.16.1.
Reimbursement limitations:
ONCOVIN
Sont remboursés
- le traitement de la leucémie aiguë;
- le traitement combiné de …
1 / 3
google
Details
- Product number
- 5364001
- CPT
- -
- Packaging group
- 5 x 2 mg/2 mL
- Unit
- Durchstechflasche(n)
- Composition
- vincristini sulfas 1 mg, mannitolum, acidum sulfuricum, natrii hydroxidum, aqua ad iniectabile q.s. ad solutionem pro 1 ml corresp. natrium 0.0138 mg.
Articles (1)
Vincristine Pfizer, Injektionslösung
Injektionslösung
5 x 2 mg/2 mL
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
1.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
0.0138 MG | Substance | HBESI |
Reimbursement information
Public price
CHF 126.30
Specialties list
Yes
Generic
Yes
Reimbursement limitation
SL addition date:
15/03/1997
Authorization holder
Pfizer AG
8052 Zürich
Authorization information
- Swissmedic authorization number
- 53640
- Drug name
- Vincristine Pfizer, Injektionslösung
- Galenic form
- LSINJ
- ATC Code
- L01CA02
- Authorization status
- Z
- Dispensation category
- A
- First authorization
- 10/09/1996
- Authorization expiration date
- 31/12/9999
- IT number
- 07.16.1.
- Domain
- Human medicine
Packaging details
- Description (FR)
- VINCRISTINE Pfizer 2 mg/2ml 5 flac 2 ml
- Description (DE)
- VINCRISTINE Pfizer 2 mg/2ml 5 Durchstf 2 ml
- Market launch
- 10/09/1996
- Narcotic (BTM)
- No